BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) - Institutionelt ejerskab - Købere

BioLineRx Ltd. - Depositary Receipt (Common Stock)

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i BioLineRx Ltd. - Depositary Receipt (Common Stock), omfatter Citadel Advisors Llc, Simplex Trading, Llc, Citadel Advisors Llc, Citigroup Inc, National Bank Of Canada /fi/, Raymond James Financial Inc, Fifth Third Bancorp, og Advisor Group Holdings, Inc. .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-05 13F Simplex Trading, Llc 14.114 0
2025-09-04 13F/A Advisor Group Holdings, Inc. 1 0
2025-08-11 13F Citigroup Inc 4.005 18
2025-08-12 13F Rhumbline Advisers 4.275 179,41 20 375,00
2025-07-15 13F Fifth Third Bancorp 25 0
2025-08-18 13F/A National Bank Of Canada /fi/ 200 1
2025-08-14 13F Citadel Advisors Llc Put 12.200 56
2025-08-14 13F Raymond James Financial Inc 72 0
2025-08-14 13F Susquehanna International Group, Llp 11.098 51
2025-08-14 13F Citadel Advisors Llc Call 43.500 199
2025-08-12 13F Proequities, Inc. 0 0
2025-08-14 13F Citadel Advisors Llc 14.954 68
Other Listings
DE:YP2
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista